China Medical System (OTCMKTS:CHSYF – Get Free Report) will likely be posting its results after the market closes on Thursday, August 13th. Analysts expect the company to post earnings of $0.0589 per share and revenue of $697.6190 million for the quarter.
China Medical System Stock Performance
OTCMKTS:CHSYF opened at $1.57 on Thursday. China Medical System has a one year low of $1.56 and a one year high of $1.57. The business’s 50-day simple moving average is $1.49 and its 200 day simple moving average is $1.40.
China Medical System Company Profile
China Medical System (OTCMKTS: CHSYF) is a China-based pharmaceutical company engaged in the research, development, manufacturing and marketing of branded generic drugs. The company focuses on therapeutic areas including cardiovascular and metabolic diseases, oncology, autoimmune disorders and central nervous system conditions. Its product portfolio comprises both patented and off‐patent medicines, with key offerings such as anti-hypertensives, antidiabetic agents, oncology treatments and neuroprotective formulations.
Founded in 1993 and headquartered in Guangzhou, China Medical System conducts its operations primarily within mainland China, leveraging an extensive sales and distribution network that reaches hospitals, clinics and specialty pharmacies across more than 30 provinces.
Recommended Stories
- Five stocks we like better than China Medical System
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for China Medical System Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Medical System and related companies with MarketBeat.com's FREE daily email newsletter.
